BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12541774)

  • 1. [The dynamic study of cytokines pre- and postoperation in patients with carcinoma of larynx].
    Wang Q; Feng Y; Zhang X; Wang H; Xu D
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Jun; 15(6):255-7. PubMed ID: 12541774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
    Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
    Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
    Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy].
    Tang L; Luo Q; Zhou X; Xia R
    Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):165-7. PubMed ID: 11955323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measurement of five cytokines in the serum of malignant lymphoma patients].
    Zhu H; Wang Y; Han X
    Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):85-8. PubMed ID: 10921109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM
    Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamic studies of NK activity, IL-2 production and sIL-2R expression in primary hepatic carcinoma patients before and after operation].
    Cao YY
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):111-3. PubMed ID: 8223118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in serum IL-2 and sIL-2R levels in patients with primary hepatic carcinoma before and after treatment and their clinical significance].
    Wang M; Feng Y; Zhou X
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):33-5. PubMed ID: 7656784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma.
    Hsiao SH; Lee MS; Lin HY; Su YC; Ho HC; Hwang JH; Lee CC; Hung SK
    Acta Otolaryngol; 2009 Dec; 129(12):1519-23. PubMed ID: 19922107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the relationship between the level of cytokine and liver function in patients with clonorchiasis sinensis].
    Cai LS; Xiao JY; Xin H; Zhu LX; Chen G; Zhang T; Wang GZ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Feb; 22(1):54-6. PubMed ID: 15283270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The soluble interleukin-2 receptor--a marker for squamous cell carcinoma of the upper aerodigestive tract.
    Gottschlich S; Görögh T; Lippert BM; Niemann AM; Folz BJ; Werner JA
    Anticancer Res; 1997; 17(4B):2921-2. PubMed ID: 9329564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Diagnostic and Prognostic Value of sIL-2R as an Immune Biomarker in Head and Neck Cancers.
    Gross M; Meirovich A; Rachmut J; Kalichman I; Peretz T; Eliashar R; Barak V
    Anticancer Res; 2016 Aug; 36(8):4347-52. PubMed ID: 27466555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamic monitoring of sIL-2R, IL-2 and IL-6 levels of serum after double-hand transplantation].
    Xiang D; Pei G; Qiu Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2004 May; 18(3):232-5. PubMed ID: 15211844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
    Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
    Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microinvasive Nd:YAG laser therapy of early glottic carcinoma and its effect on soluble interleukin-2 receptor, interleukin-2, and natural killer cells.
    Lai JP; Tao ZD; Xiao JY; Chen XH; Zhao SP; Tian YQ; Betz CS
    Laryngoscope; 2001 Sep; 111(9):1585-8. PubMed ID: 11568609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
    Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indices of immune activation after bronchial carcinoma surgery.
    Sawa A; Kozioł-Montewka M; Goździuk K; Roliński J; Iłzecki M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):161-6. PubMed ID: 15314978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
    Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.